ArticleDiabetes, obesity & metabolism2026
Health Care Provider Perceptions of Screening for Early-Stage Type 1 Diabetes-A Survey Study.
Article in Diabetes, obesity & metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
aimsTo evaluate the feasibility, perceived benefits, and challenges of integrating early-stage Type 1 diabetes screening and monitoring into routine care. MATERIALS AND
methodsPrimary health care providers (HCPs; n = 683), responsible for collecting capillary blood samples and obtaining informed consent, and specialised diabetes centres (n = 17), responsible for monitoring children with early-stage Type 1 diabetes using oral glucose tolerance tests (OGTT) and HbA1c, within an early-stage Type 1 diabetes screening programme in Bavaria, Germany (Fr1da) were invited to participate in an online survey.
resultsAmong the 194 responding primary HCPs, 66% rated overall feasibility of integrating screening in routine care as 'very good' or 'good'. More than 70% rated informing families about screening and communicating results positively, while 54% rated capillary blood sampling positively. Among the 10 responding diabetes centres, ≥ 80% rated feasibility of OGTT and HbA1c positively. Families' acceptance of glucose (on-site or at-home) and HbA1c monitoring was perceived as high. Screening was considered beneficial by 91% of primary HCPs and by all diabetes centres, emphasising reduced efforts for insulin initiation and long-term care. Reported key challenges included time and staffing constraints and inadequate reimbursement.
conclusionsRoutine-care implementation of early-stage Type 1 diabetes screening is broadly supported by primary HCPs and diabetes centres and could be facilitated by refined workflows and appropriate reimbursement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.